Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Multicenter, Open-label, Expanded Access Study of KTE-X19 for the Treatment of Subjects with Relapsed/Refractory B-Cell Malignancies (ZUMA-18)
Lymphoma
Lymphoma
Lymphoma
II
Oluwole, Olalekan
NCT04162756
VICCCTT19124